Omnitrope and Constipation - a phase IV clinical study of FDA data

Summary:

Constipation is reported as a side effect among people who take Omnitrope (somatropin recombinant), especially for people who are male, 2-9 old, have been taking the drug for < 1 month also take Fluoxetine, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Constipation when taking Omnitrope. It is created by eHealthMe based on reports of 8,562 people who have side effects when taking Omnitrope from the FDA, and is updated regularly.

What is Omnitrope?

Omnitrope has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 8,582 Omnitrope users. Check the latest studies of Omnitrope.

What is Constipation?

Constipation is found to be associated with 3,001 drugs and 4,563 conditions by eHealthMe. Check the latest studies of Constipation.

On Oct, 14, 2025

8,562 people reported to have side effects when taking Omnitrope.
Among them, 35 people (0.41%) have Constipation.

Among these 35 people:

How long have people been on Omnitrope when they have Constipation? *

What is the gender of people who have Constipation when taking Omnitrope? *

female: 44.12 %
male: 55.88 %

What is the age of people who have Constipation when taking Omnitrope? *

What are other drugs people take besides Omnitrope? *

What are other side effects people have besides Constipation? *

Headache (pain in head): 5 people, 14.29%
Dry Skin: 4 people, 11.43%
Fever: 3 people, 8.57%
The Flu (the flu is caused by an influenza virus): 3 people, 8.57%
Dyspnea (difficult or laboured breathing): 3 people, 8.57%
Injection Site Bruising: 3 people, 8.57%
Bedwetting: 2 people, 5.71%
Fatigue (feeling of tiredness): 2 people, 5.71%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 5.71%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 5.71%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 8 people, 22.86%
Growth Retardation (delayed growth): 3 people, 8.57%
Sheehan Syndrome (severe bleeding during childbirth can result in tissue death in the pituitary gland. this causes the gland to lose its ability to work properly): 2 people, 5.71%
Urinary Tract Infection: 1 person, 2.86%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.86%
Body Height Below Normal: 1 person, 2.86%
Depression: 1 person, 2.86%
Diabetes: 1 person, 2.86%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 2.86%
Foetal Growth Restriction (poor growth of a baby while in the mother's womb during pregnancy): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Omnitrope and have Constipation?

- Check whether Constipation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omnitrope:

Omnitrope (8,582 reports)

Constipation treatments and more:

Constipation (337,848 reports)

Browse all side effects of Omnitrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Constipation:

Constipation (3,001 drugs)

Browse all the conditions that are associated with Constipation:

Constipation (4,563 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Omnitrope) and Omnitrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.